Literature DB >> 19760158

Demographic characteristics of hospitalized IBD patients.

Amnon Sonnenberg1.   

Abstract

BACKGROUND AND AIMS: The Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project (HCUP) was used to study the recent demographic characteristics of patients with Crohn's disease (CD) or ulcerative colitis (UC).
METHODS: HCUP data of the period 1997-2006 were extracted. The data were stratified by the categories pertaining to patient demographics, such as age-group, sex, race, insurance type, income group, residence in metropolitan area and region of the United States, as well as categories pertaining to hospital characteristics, such as type of ownership, teaching status, location, and bed-size. The distributions of inpatients among different categories were compared between CD or UC and all other diagnoses, using odds ratios and their 95% confidence intervals for comparison.
RESULTS: The data revealed a slight female predominance in CD (1.08, 1.09-1.09) and a slight male predominance in UC (1.15, 1.14-1.15). Compared to patients with other diagnoses, patients with inflammatory bowel disease tended to be white (CD: 2.47, 2.45-2.50; UC: 2.13, 2.10-2.15), more affluent (CD: 1.44, 1.43-1.45; UC: 1.59, 1.58-1.61), live in metropolitan areas (CD: 1.09, 1.08-1.10; UC: 1.26, 1.25-1.27) and in the Northeast of the United States (CD: 1.27, 1.27-1.28; UC: 1.44, 1.43-1.45).
CONCLUSIONS: These patterns confirm previously described characteristics of patients with inflammatory bowel disease and show that such characteristics still apply to present patient populations.

Entities:  

Mesh:

Year:  2009        PMID: 19760158     DOI: 10.1007/s10620-009-0973-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis.

Authors:  J F Blanchard; C N Bernstein; A Wajda; P Rawsthorne
Journal:  Am J Epidemiol       Date:  2001-08-15       Impact factor: 4.897

Review 2.  The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed?

Authors:  Anders Ekbom
Journal:  Inflamm Bowel Dis       Date:  2004-02       Impact factor: 5.325

Review 3.  Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases.

Authors:  Charles N Bernstein; Fergus Shanahan
Journal:  Gut       Date:  2008-05-30       Impact factor: 23.059

4.  Occupational mortality of inflammatory bowel disease.

Authors:  A Sonnenberg
Journal:  Digestion       Date:  1990       Impact factor: 3.216

5.  Occupational distribution of inflammatory bowel disease among German employees.

Authors:  A Sonnenberg
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 6.  Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

Authors:  Peter-Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2006-10-14       Impact factor: 5.742

Review 7.  Inflammatory bowel disease in African Americans.

Authors:  Sarathchandra I Reddy; Robert Burakoff
Journal:  Inflamm Bowel Dis       Date:  2003-11       Impact factor: 5.325

8.  Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume.

Authors:  Ashwin N Ananthakrishnan; Emily L McGinley; David G Binion
Journal:  Am J Gastroenterol       Date:  2008-08-05       Impact factor: 10.864

Review 9.  Epidemiology of inflammatory bowel disease in Asia.

Authors:  Ajit Sood; Vandana Midha
Journal:  Indian J Gastroenterol       Date:  2007 Nov-Dec

Review 10.  Gender differences in health care expenditures, resource utilization, and quality of care.

Authors:  Gary M Owens
Journal:  J Manag Care Pharm       Date:  2008-04
View more
  8 in total

1.  Health Insurance Paid Costs and Drivers of Costs for Patients With Crohn's Disease in the United States.

Authors:  K T Park; Richard B Colletti; David T Rubin; Bal K Sharma; Amy Thompson; Andrew Krueger
Journal:  Am J Gastroenterol       Date:  2015-07-21       Impact factor: 10.864

Review 2.  Challenges in designing a national surveillance program for inflammatory bowel disease in the United States.

Authors:  Millie D Long; Susan Hutfless; Michael D Kappelman; Hamed Khalili; Gilaad G Kaplan; Charles N Bernstein; Jean Frederic Colombel; Corinne Gower-Rousseau; Lisa Herrinton; Fernando Velayos; Edward V Loftus; Geoffrey C Nguyen; Ashwin N Ananthakrishnan; Amnon Sonnenberg; Andrew Chan; Robert S Sandler; Ashish Atreja; Samir A Shah; Kenneth J Rothman; Neal S Leleiko; Renee Bright; Paolo Boffetta; Kelly D Myers; Bruce E Sands
Journal:  Inflamm Bowel Dis       Date:  2014-02       Impact factor: 5.325

3.  The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.

Authors:  K T Park; Orna G Ehrlich; John I Allen; Perry Meadows; Eva M Szigethy; Kim Henrichsen; Sandra C Kim; Rachel C Lawton; Sean M Murphy; Miguel Regueiro; David T Rubin; Nicole M Engel-Nitz; Caren A Heller
Journal:  Inflamm Bowel Dis       Date:  2020-01-01       Impact factor: 5.325

4.  Does patient engagement affect IBD patients' health-related quality of life? Findings from a cross-sectional study among people with inflammatory bowel diseases.

Authors:  Serena Barello; Elena Guida; Salvatore Leone; Enrica Previtali; Guendalina Graffigna
Journal:  Health Qual Life Outcomes       Date:  2021-03-07       Impact factor: 3.186

Review 5.  The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2016-01-08

6.  Investigation of Geriatric Patients with Abdominal Pain Admitted to Emergency Department.

Authors:  Pınar Henden Çam; Ahmet Baydin; Savaş Yürüker; Ali Kemal Erenler; Erdinç Şengüldür
Journal:  Curr Gerontol Geriatr Res       Date:  2018-05-30

7.  Ultraviolet Irradiation of Skin Alters the Faecal Microbiome Independently of Vitamin D in Mice.

Authors:  Simon Ghaly; Nadeem O Kaakoush; Frances Lloyd; Lavinia Gordon; Cynthia Forest; Ian C Lawrance; Prue H Hart
Journal:  Nutrients       Date:  2018-08-11       Impact factor: 5.717

8.  Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients.

Authors:  Mohammed Al Fadda; Musthafa Chalikandy Peedikayil; Ingvar Kagevi; Khalid Al Kahtani; Ali Al Ben; Hamad Ibrahim Al; Fahad Al Sohaibani; Mohammed Al Quaiz; Maheeba Abdulla; Mohammed Qaseem Khan; Ahmed Helmy
Journal:  Ann Saudi Med       Date:  2012 May-Jun       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.